Vertex Pharmaceuticals Heading $600? A Stock Outlook
Investors keep asking if Vertex Pharmaceuticals is headed to $600. This article breaks down the core business, pipeli...
When To Shift From Stocks To Bonds
Understanding when to shift from stocks to bonds can enhance your investment strategy. Make informed decisions to maximize returns.
22,202 articles
Hormuz Route Open Despite Iran Declaration, Group Says
Maritime officials say the southern Hormuz corridor remains open despite Iran’s blockade claim, keeping a key energy ...
Nebius Just Cemented Lead as Premier Neocloud Stock
Nebius inked a $27 billion AI infrastructure deal with Meta, locking in vast capacity and signaling its edge in the n...
Bitcoin’s $60K Price Floor Holds as Hormuz Shock Returns
Bitcoin steadied near the $60,000 level as tensions in the Strait of Hormuz pushed oil higher and equity futures retr...
Ethereum Founder Vitalik Buterin Wants Node Setup Simpler
The push to lower the bar for running Ethereum nodes is gaining momentum. This piece explores Vitalik Buterin's call ...
Missed GE’s Aerospace Rally? XLI Still Edges GE Stock
GE Aerospace delivered strong results in 2026, but the broader XLI index outpaced the stock through July. Here's what...
Dalio Warns Brutal ‘Final’ Hormuz Clash Reshape Markets
Bridgewater founder Ray Dalio warns a brutal ‘final’ clash at the Strait of Hormuz could decide whether the U.S.-led ...
Kogevinas Group Joins Sotheby’s in Montecito Relaunch
A veteran Southern California luxury team is switching brokerages, moving to Sotheby’s International Realty – Monteci...
Mastercard Acquire Crypto Startup BVNK for Up to $1.8B
Mastercard plans to buy London-based BVNK for up to $1.8 billion, creating the largest stablecoin deal to date and ac...
States Call Businesses with Medicaid Employees Spotlight
With federal Medicaid work requirements looming, several states are pushing legislation to publicly name big employer...
Lilly Falls on Oral Obesity Pill as FDA Decision Looms
Eli Lilly stock fell about 5% as investors awaited the FDA's April decision on orforglipron. Novo Nordisk's intensifi...
Broad Industrials Fine: This AI Build-Out Drives Gains
A focused infrastructure fund rode the AI build-out to roughly 28% gains through mid-2026, underscoring how concentra...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status